Abstracts

LIMIT OF DETECTION OF SARS-CoV-2 ANTIBODY ASSAYS

Seroprevalence studies of antibodies to SARS-CoV-2 are important for public health surveillance. Recent studies have shown that antibodies to SARS-CoV-2, both from natural infection and vaccination, decrease with time from exposure. Variation in the performance of antibody assays will impact the estimates of SARS-CoV-2 exposure and vaccination levels in a population. Using standardized serial dilutions,…

DEVELOPMENT OF A HIGH-THROUGHPUT NGS WORKFLOW FOR SARS-CoV-2 WHOLE-GENOME SEQUENCING

Monitoring new mutations in SARS-CoV-2 is crucial for identifying diagnostic and therapeutic targets and important insights to achieve a more effective COVID-19 control strategy. Next-generation sequencing (NGS) has been widely used for whole-genome sequencing of SARS-CoV-2. However, NGS methods may be limited by the complexity of workflow, which limits scalability. Here, we address this limitation…

UTILITY OF COVID-19 POINT-OF-CARE ANTIGEN TESTS IN LOW-MIDDLE INCOME SETTINGS

Access to SARS-CoV-2 polymerase chain reaction (PCR) testing is a bottleneck globally, especially in low- and middle-income countries (LMICs). Reliable point-of- care (POC) diagnostics for coronavirus disease 2019 (COVID-19) are cheaper and easier to scale-up than PCR especially in LMICs, and will facilitate interruption of transmission. We report the field-based effectiveness of rapid point-of-care (POC)…

POINT-OF-CARE ANTIBODY TESTS FOR COVID-19: FIELD-BASED PERFORMANCE, SOUTH AFRICA

SARS-CoV2 antibody testing is an important auxillary test especially for retrospective diagnosis or in patients with long COVID-19 or multisystem inflammatory syndrome of childhood. Epidemiological serology studies may also assist public health planning. Access to formal laboratory testing is not universal in many low-and middle-income (LMIC) countries and rapid lateral flow antibody tests are an…

PERFORMANCE OF SARS-CoV-2 ANTIBODY ASSAYS IN A NATIONAL SEROSURVEY IN SOUTH AFRICA

Accurate and reliable serological assays are essential for epidemiological surveillance of SARS-CoV-2. Several commercial anti-SARS assays are available and use cases for serological testing includes surveillance. However, there is growing evidence of varying performance of SARS-CoV-2 assays dependent of their format. We compare the performance of 3 different assays used in a national serosurvey undertaken…

PRE-PANDEMIC SARS-CoV-2 SEROPOSITIVITY AMONG PREGNANT WOMEN – ZAMBIA, 2017-2018

Reliable serologic assays are needed to accurately measure prevalence of prior exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, several countries in Africa have reported apparent SARS-CoV-2 assay cross-reactivity with other non-coronavirus pathogens. We used 3 SARS-CoV-2 serologic assays to assess positivity in archived serum specimens collected in Zambia prior to the COVID-19…